Literature DB >> 21297446

Pdx1 expression in pancreatic precursor lesions and neoplasms.

Jason Y Park1, Seung-Mo Hong, David S Klimstra, Michael G Goggins, Anirban Maitra, Ralph H Hruban.   

Abstract

Pancreatic and duodenal homeobox (Pdx1) is a homeobox transcription factor required for the embryonic development of the pancreas. Pdx1 expression has been earlier identified in pancreatic ductal adenocarcinomas and endocrine neoplasms. This study characterizes Pdx1 protein expression in pancreatic precursor lesions and neoplasms, including pancreatic intraepithelial neoplasia (PanIN, n=32), intraductal papillary mucinous neoplasm (IPMN, n=88), mucinous cystic neoplasm (MCN, n=3), acinar cell carcinoma (ACC, n=8), pancreatic endocrine neoplasm (PEN, n=44), pancreatoblastoma (PB, n=1), solid pseudopapillary neoplasm (n=8), invasive ductal adenocarcinoma (n=67), and nondysplastic ductal epithelium. A mouse monoclonal antibody for Pdx1 was used to examine archived surgical pathology cases and tissue microarrays containing >655 tissue cores from more than 250 pancreatic specimens. Immunohistochemical labeling for Pdx1 was performed using standard methods and scored for percentage and intensity of nuclear labeling. Among non-neoplastic pancreatic tissues, Pdx1 nuclear protein was expressed in islet cells, cells of the centroacinar cell compartment, and non-neoplastic ductal epithelium. No expression of Pdx1 was seen in non-neoplastic acinar cells. Among pancreatic neoplasms, Pdx1 consistently labeled >50% of the tumor cells in 87.5% of ACC cases and 38.6% of PEN cases. Pdx1 expression was variable in invasive ductal adenocarcinoma and precursor lesions of ductal adenocarcinomas (PanIN, IPMN, and MCN). A single case of PB was examined and it showed Pdx1 in the acinar component, but no expression in squamoid nests. Solid pseudopapillary neoplasms did not express Pdx1. This study shows Pdx1 expression in precursor lesions of ductal adenocarcinomas, PEN, ACC, and a case of PB. In the immunohistochemical evaluation of neoplasms of the pancreas, Pdx1 expression is not a finding specific to PENs and ductal adenocarcinomas, but also occurs in precursor lesions (PanIN, IPMN, MCN) and other neoplasms of the pancreas.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21297446      PMCID: PMC3123421          DOI: 10.1097/PAI.0b013e318206d958

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  20 in total

1.  Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence.

Authors:  D A Stoffers; N T Zinkin; V Stanojevic; W L Clarke; J F Habener
Journal:  Nat Genet       Date:  1997-01       Impact factor: 38.330

2.  The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration.

Authors:  A Sharma; D H Zangen; P Reitz; M Taneja; M E Lissauer; C P Miller; G C Weir; J F Habener; S Bonner-Weir
Journal:  Diabetes       Date:  1999-03       Impact factor: 9.461

3.  Cell-specific cytotoxicity of human pancreatic adenocarcinoma cells using rat insulin promoter thymidine kinase-directed gene therapy.

Authors:  Thomas A Tirone; Xaio-Ping Wang; Nancy S Templeton; Tim Lee; Liz Nguyen; William Fisher; F Charles Brunicardi
Journal:  World J Surg       Date:  2004-08-03       Impact factor: 3.352

4.  Insulin-promoter-factor 1 is required for pancreas development in mice.

Authors:  J Jonsson; L Carlsson; T Edlund; H Edlund
Journal:  Nature       Date:  1994-10-13       Impact factor: 49.962

5.  Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray.

Authors:  Anirban Maitra; N Volkan Adsay; Pedram Argani; Christine Iacobuzio-Donahue; Angelo De Marzo; John L Cameron; Charles J Yeo; Ralph H Hruban
Journal:  Mod Pathol       Date:  2003-09       Impact factor: 7.842

6.  PDX1 homeobox protein expression in pseudopyloric glands and gastric carcinomas.

Authors:  H Sakai; Y Eishi; X-L Li; Y Akiyama; S Miyake; T Takizawa; N Konishi; M Tatematsu; M Koike; Y Yuasa
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

Review 7.  PDX-1 and the pancreas.

Authors:  Satoshi Ashizawa; F Charles Brunicardi; Xiao-Ping Wang
Journal:  Pancreas       Date:  2004-03       Impact factor: 3.327

8.  Ductuloinsular tumors of the pancreas: endocrine tumors with entrapped nonneoplastic ductules.

Authors:  Susanne van Eeden; Wendy W J de Leng; G Johan A Offerhaus; Folkert H Morsink; Marian A J Weterman; Ronald R de Krijger; Günter Klöppel; David S Klimstra
Journal:  Am J Surg Pathol       Date:  2004-06       Impact factor: 6.394

9.  Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors.

Authors:  Guoqiang Gu; Jolanta Dubauskaite; Douglas A Melton
Journal:  Development       Date:  2002-05       Impact factor: 6.868

10.  Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras.

Authors:  Sharon Y Gidekel Friedlander; Gerald C Chu; Eric L Snyder; Nomeda Girnius; Gregory Dibelius; Denise Crowley; Eliza Vasile; Ronald A DePinho; Tyler Jacks
Journal:  Cancer Cell       Date:  2009-11-06       Impact factor: 31.743

View more
  24 in total

1.  Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors.

Authors:  Shinichi Yachida; Efsevia Vakiani; Catherine M White; Yi Zhong; Tyler Saunders; Richard Morgan; Roeland F de Wilde; Anirban Maitra; Jessica Hicks; Angelo M Demarzo; Chanjuan Shi; Rajni Sharma; Daniel Laheru; Barish H Edil; Christopher L Wolfgang; Richard D Schulick; Ralph H Hruban; Laura H Tang; David S Klimstra; Christine A Iacobuzio-Donahue
Journal:  Am J Surg Pathol       Date:  2012-02       Impact factor: 6.394

Review 2.  The role of lineage specifiers in pancreatic ductal adenocarcinoma.

Authors:  Soledad A Camolotto; Veronika K Belova; Eric L Snyder
Journal:  J Gastrointest Oncol       Date:  2018-12

3.  Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2.

Authors:  Gratiana Hermann; Björn Konukiewitz; Anja Schmitt; Aurel Perren; Günter Klöppel
Journal:  Virchows Arch       Date:  2011-07-08       Impact factor: 4.064

Review 4.  Acinar cell plasticity and development of pancreatic ductal adenocarcinoma.

Authors:  Peter Storz
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-03-08       Impact factor: 46.802

5.  Expression of master regulatory genes of embryonic development in pancreatic tumors.

Authors:  L G Kondratyeva; I P Chernov; M V Zinovyeva; E P Kopantzev; E D Sverdlov
Journal:  Dokl Biochem Biophys       Date:  2017-09-02       Impact factor: 0.788

Review 6.  Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.

Authors:  Thomas S Frank; Xiaotian Sun; Yuqing Zhang; Jingxuan Yang; William E Fisher; Marie-Claude Gingras; Min Li
Journal:  Cancer Lett       Date:  2015-04-15       Impact factor: 8.679

Review 7.  Regenerative medicine and cell-based approaches to restore pancreatic function.

Authors:  Cara Ellis; Adam Ramzy; Timothy J Kieffer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-08-16       Impact factor: 46.802

Review 8.  Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms.

Authors:  Silvia Uccella; Stefano La Rosa; Marco Volante; Mauro Papotti
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

9.  Disputed paternity: the uncertain ancestry of pancreatic ductal neoplasia.

Authors:  Anirban Maitra; Steven D Leach
Journal:  Cancer Cell       Date:  2012-12-11       Impact factor: 31.743

10.  Human urine-derived stem cells play a novel role in the treatment of STZ-induced diabetic mice.

Authors:  Tianxue Zhao; Deng Luo; Yun Sun; Xin Niu; Yang Wang; Chen Wang; Weiping Jia
Journal:  J Mol Histol       Date:  2018-04-19       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.